Skip to main content
Caplight Logo









Tay Therapeutics

Tay Therapeutics

Private
DundeeHealthcare & Life Scienceshttps://taytherapeutics.com/

Last Round

Grant

Oct 1, 2023

Total Funding Raised

$430,000

Company Overview

Tay Therapeutics is a biotechnology company that develops targeted small molecule therapies for inflammatory conditions and rare genetic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

small molecule drug discoverybiotech licensingrare genetic diseasesdrug discovery platformBET inhibitorpremature stop codonssemi-virtual biotechcontract research organizationCROdrug development pipelinevirtual biotechout-licensingdrug asset licensingbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tay Therapeutics Comparables

Compare Tay Therapeutics with similar companies based on industry and business-model similarity.

Tay Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nonsense Therapeutics
92%
Eloxx Pharmaceuticals, Inc.
77%
Anima Biotech
73%

Tay Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 1, 2023
VC RoundNov 2, 2021
SeedNov 27, 2020

Key People

Founding team and executive leadership

Andrew Woodland

Chief Executive Officer

Executive Team

Mark Bell

CTO

Executive Team

Conor Woolfson

Chief Financial Officer

Executive Team

Tay Therapeutics Investors

Notable investors and investment history

Tay Therapeutics investors
InvestorRounds
o2h venturesSeed, VC Round
Meltwind AdvisorySeed, VC Round
Innovate UKGrant
Wren CapitalSeed, VC Round
Scottish Investment Bank (Scottish Enterprise)Seed, VC Round
University of DundeeVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 1, 2023

    $430K grant received from Innovate UK.

  • Nov 2, 2021

    $2.18M round led by o2h ventures.

Tay Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Tay Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Tay Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersDundee
Employee Range7
Year Founded2020
Last FundingOct 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?